Article Information
PubMed
Print ISSN
Online ISSN
History
- Received January 25, 2008
- Accepted April 16, 2008
- Published online June 18, 2008.
Article Versions
- Earlier version (April 18, 2008 - 08:53).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Marie-Claude Lauzier,
- Geneviève A. Robitaille,
- Denise A. Chan,
- Amato J. Giaccia and
- Darren E. Richard
- Centre de recherche de L'Hôtel-Dieu de Québec and the Department of Medicine, Université Laval, Québec, Canada (M.C.L., G.A.R., D.E.R.); and Center for Clinical Science Research, Department of Radiation Oncology, Stanford University, Stanford, California (D.A.C., A.J.G.)
- Address correspondence to:
Dr. Darren E. Richard, Centre de recherche de L'Hôtel-Dieu de Québec, 10 Rue McMahon, Québec QC G1R 2J6, Canada. E-mail: darren.richard{at}crhdq.ulaval.ca
Statistics from Altmetric.com
Article usage
In this issue
(2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide (BiPS), a Matrix Metalloprotease Inhibitor, Is a Novel and Potent Activator of Hypoxia-Inducible Factors
